ProQR Therapeutics presents data on Axiomer RNA Editing technology

ProQR Therapeutics announced a presentation at the RNA Editing Summit, July 11-13, 2023 in Boston, MA, USA. The 2023 edition of the RNA Editing Summit will focus on optimizing RNA editing technology to safely deliver novel payloads, enhancing potency and durability to achieve clinical validation in patients faster. This presentation will detail: Ongoing effort led by ProQR to put in place effective strategies to increase RNA editing yields of ADARs using chemical modifications and oligonucleotide design; The potential of the Axiomer platform in multiple organs, as well as its applicability for the treatment of liver-originated disorders, including data from preclinical models.